Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

499.17
+38.308.31%
Post-market: 499.00-0.1700-0.03%19:52 EDT
Volume:3.36M
Turnover:1.68B
Market Cap:126.65B
PE:32.58
High:507.92
Open:482.25
Low:477.77
Close:460.87
52wk High:519.68
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:3.05
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.32
EPS(LYR):15.32
ROE:22.54%
ROA:12.16%
PB:6.79
PE(LYR):32.58

Loading ...

Vertex Pharmaceuticals Files Initial Statement of Beneficial Ownership for Mark E. Bunnage, EVP and Chief Scientific Officer

Reuters
·
Feb 04

Vertex Report: U.S. Sees Record-Level Growth in Sales Tax Rates and Rules Changes in 2025 Amid Fiscal Uncertainty

GlobeNewswire
·
Feb 03

Piper Sandler Downgrades Vertex to Neutral From Overweight

MT Newswires Live
·
Feb 03

Vertex Cut to Neutral From Overweight by Piper Sandler

Dow Jones
·
Feb 03

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Brookdale Senior Living (BKD)

TIPRANKS
·
Feb 03

WuXi Biologics schließt Lizenz- und Forschungsdienstleistungsvertrag mit Vertex Pharmaceuticals für T-Zell-Engager ab

Reuters
·
Feb 03

Vertex Minerals Reaffirms JORC-Compliant Gold Resource Position at Reward Mine

TIPRANKS
·
Feb 03

Vertex Minerals Strengthens Leadership to Drive Reward Gold Mine Production Ramp-Up

TIPRANKS
·
Feb 02

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jan 31

Vertex Ramps Up Underground Production at Reward Gold Mine and Bolsters Funding

TIPRANKS
·
Jan 30

Assessing Vertex Pharmaceuticals (VRTX) Valuation After Fund Exit And Setback For Journavx Pain Label

Simply Wall St.
·
Jan 29

Satellos Bioscience Appoints Antoinette Paone as Chief Development Officer

Reuters
·
Jan 29

Vertex Pharmaceuticals Raised to Overweight From Equal-Weight by Barclays

Dow Jones
·
Jan 28

Vertex Pharmaceuticals assumed with Overweight from Equal Weight at Barclays

TIPRANKS
·
Jan 28

Vertex Pharmaceuticals (VRTX) Receives a Buy from Citi

TIPRANKS
·
Jan 27

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 27

Vertex Pharmaceuticals Is Maintained at Buy by UBS

Dow Jones
·
Jan 27

Vertex Pharmaceuticals price target raised to $545 from $535 at UBS

TIPRANKS
·
Jan 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Corcept Therapeutics (CORT), Intuitive Surgical (ISRG) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jan 23

Vertex Pharmaceuticals price target raised to $530 from $475 at Evercore ISI

TIPRANKS
·
Jan 23